Nasdaq slips on Broadcom, Dow boosted by health care and financial components

U.S. markets were mixed as the S&P 500 was flat at 7,553.41, the NASDAQ fell 0.7%, and the Dow rose 1.3%, with Broadcom sliding 14.6% after earnings guidance disappointed despite 48% Q2 revenue growth. Semiconductor weakness was partly offset by strength in healthcare and continued AI enthusiasm, while Middle East tensions and oil-price moves kept the market risk backdrop elevated. Brent crude fell 2.7% to $95.19 and WTI dropped 3.5% to $92.69, while 2-year and 10-year Treasury yields eased on the day.

Analysis

The market’s message is that AI capex remains the dominant secular driver, but leadership is narrowing. Broadcom’s weak post-print reaction is less about one company and more about the fact that the “infrastructure beneficiaries” trade is now vulnerable to any miss on guide quality; names with long duration AI narratives and rich multiples are most exposed to multiple compression, while the actual end-demand leaders can keep absorbing volatility. That creates a second-order rotation from semis with stretched expectations into platform-scale buyers and monetizers of AI compute, where earnings visibility is better and valuation support is less fragile.

The bigger macro tell is that geopolitics is now acting more through rates than through equities directly. If energy stays elevated, the Fed can keep the front end tighter for longer, which pressures the highest-duration parts of tech first; even modest changes in 2-year yields matter more for semis and software than for healthcare or cash-rich mega-cap platforms. The immediate consequence is that “buy the dip” still works on the index, but not indiscriminately — the dip is more likely to be bought in AI demand winners and defensives than in cyclically levered chip names.

The contrarian read is that the selloff in semis may already be doing the job of resetting expectations faster than fundamentals are deteriorating. If Friday labor data softens without a growth scare, the market can quickly re-price toward a lower-rate path, which would mechanically support high-multiple tech and short-duration growth. So the near-term risk is not a broad equity correction; it is a factor rotation where earnings disappointments in the AI supply chain get punished harder than the index, while the broader market stays resilient.

Key Decisions for Investors

• Short AVGO / long META for 2-6 weeks: express the view that AI monetization platforms are less exposed to capex-trajectory disappointment than the infrastructure layer. Target 5-8% relative outperformance if semis remain under pressure; cut if AVGO reclaims post-earnings gap levels.
• Buy AMD or ARM downside hedges, not outright shorts, into the next 1-3 weeks: the trade is for further multiple compression from sentiment spillover, but the names remain hostage to any macro relief. Prefer put spreads 5-10% OTM to keep theta manageable.
• Add to SMCI only on broad tech weakness, not on semis strength: it is the cleanest momentum expression if rates fall and AI spend remains intact, but it should be treated as a high-beta trading position with 10-15% downside risk if yields re-accelerate.
• Long QQQ / short XLU or XLV as a tactical pair over the next month: if geopolitical risk starts to fade and Friday payrolls do not re-ignite rate fears, index upside should be led by growth, while defensives give back part of their flight-to-quality premium.
• If oil stays firm and 2-year yields remain elevated, rotate a portion of tech exposure into cash-rich mega-cap AI winners with actual monetization power; avoid the most guidance-sensitive semis until the next batch of earnings resets the bar.